Holen Sie sich die Stockscreener-App
29.32
2.27%
-0.68
Schlusskurs vom Vortag:
$30.00
Offen:
$30.57
24-Stunden-Volumen:
645.98K
Relative Volume:
1.47
Marktkapitalisierung:
$344.61M
Einnahmen:
$7.49M
Nettoeinkommen (Verlust:
$-360.50M
KGV:
-0.7095
EPS:
-41.3227
Netto-Cashflow:
$-33.68M
1W Leistung:
-0.74%
1M Leistung:
+29.73%
6M Leistung:
+5.20%
1J Leistung:
+112.93%
1-Tages-Spanne:
$28.93
$30.68
1-Wochen-Bereich:
$28.93
$33.38
52-Wochen-Spanne:
$11.39
$37.83
Surrozen Inc Stock (SRZN) Company Profile
Firmenname
Surrozen Inc
Sektor
Branche
Telefon
650-475-2820
Adresse
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
29.32 | 347.20M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | TD Cowen | Buy |
| 2026-02-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-09-15 | Eingeleitet | Guggenheim | Buy |
| 2021-09-07 | Eingeleitet | Stifel | Buy |
Alle ansehen
Surrozen Inc Aktie (SRZN) Neueste Nachrichten
Commodore Capital reports a passive stake above 5% in Surrozen (SRZN). - Stock Titan
LifeSci Capital Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $54 - Moomoo
Surrozen Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Surrozen Price Target Raised to $54.00/Share From $44.00 by HC Wainwright & Co. - Moomoo
Two new option listings and eight option delistings on September 21st - TipRanks
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation By Investing.com - Investing.com South Africa
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation - Investing.com
Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower I - Benzinga
(SRZN) Risk Channels and Responsive Allocation - Stock Traders Daily
DME red flag in Merck Brunello phase III? Surrozen finishes rich - BioWorld News
SRZN Price Today: Surrozen, Inc. Stock Price, Quote & Chart | MEXC - MEXC
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
Crude Oil Rises Over 4%; Darden Earnings Miss Views - benzinga.com
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy - Benzinga
Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone - Quiver Quantitative
SRZN Options Volatility — NASDAQ:SRZN - TradingView
SRZN Options Chain — NASDAQ:SRZN - TradingView
Surrozen, Inc.(NasdaqCM: SRZN) added to S&P Global BMI Index - marketscreener.com
Surrozen at Morgan Stanley conference: eyeing dual-action edge - Investing.com
Surrozen at Morgan Stanley conference: eyeing dual-action edge By Investing.com - Investing.com Canada
(SRZN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Surrozen submits IND to FDA for DME therapeutic - Glance by Eyes On Eyecare
Surrozen at Cantor healthcare conference: eye drug strategy takes shape - Investing.com
Surrozen at Cantor healthcare conference: eye drug strategy takes shape By Investing.com - Investing.com Canada
Guggenheim Names Top Biotechnology Stock Pick By Investing.com - Investing.com India
Surrozen files SZN-8141 IND application for DME - BioWorld News
Guggenheim Names Top Biotechnology Stock Pick - Investing.com
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema - markets.businessinsider.com
Surrozen Files Investigational New Drug Application for SZN-8141 in Diabetic Macular Edema - marketscreener.com
One drug combines two approaches for diabetic vision loss. Surrozen submitted an application to the FDA. - Stock Titan
Surrozen Inc. Warrant (SRZNW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Discipline and Rules-Based Execution in SRZN Response - Stock Traders Daily
Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewswire
Surrozen Inc. Warrant (SRZNW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Surrozen Inc. Warrant (SRZNW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Surrozen Inc. Warrant (SRZNW) Peer Comparison – Compare with Others - Value Research
William Blair Upgrades Surrozen (NASDAQ:SRZN) to "Strong-Buy" - MarketBeat
William Blair Initiates Surrozen at Outperform - marketscreener.com
William Blair initiates Surrozen stock with Outperform rating By Investing.com - Investing.com Canada
William Blair initiates Surrozen stock with Outperform rating - Investing.com
Surrozen (SRZN) Q2 2026 Results: Profit Per Share Clears Its Benchmark on the Day; Market Reaction - vinanet.vn
Guggenheim Names Top Stock Pick in Biotech Sector By Investing.com - Investing.com Nigeria
LifeSci Capital Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $46 - Moomoo
SRZN Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers Strong Beat as Stage Remains Pre-Revenue - vinanet.vn
Braidwell group reports 3.9% Surrozen (SRZN) holding in amended 13G filing - Stock Titan
Surrozen (SRZN): Boxer Capital group discloses 8.9% ownership stake in 13G/A - Stock Titan
Liquidity Mapping Around (SRZN) Price Events - Stock Traders Daily
StemPoint Capital reports 5.0% Surrozen (SRZN) stake via shares and warrants - Stock Titan
Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts - simplywall.st
What is HC Wainwright's Estimate for Surrozen Q3 Earnings? - MarketBeat
Finanzdaten der Surrozen Inc-Aktie (SRZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surrozen Inc-Aktie (SRZN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research |
May 04 '26 |
Sale |
33.33 |
1,584 |
52,799 |
17,216 |
| Williams Charles O | Chief Operating Officer |
May 04 '26 |
Sale |
33.33 |
2,036 |
67,866 |
16,571 |
| Parker Craig C | Chief Executive Officer |
May 04 '26 |
Sale |
33.33 |
4,524 |
150,798 |
16,553 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 24 '26 |
Buy |
24.69 |
106,658 |
2,633,717 |
736,554 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):